5 results
To compare the overall survival (OS) of sacituzumab govitecan (SG) versus docetaxel.
The aim of this study is to investigate whether postoperative ventilation with INTELLiVENT-ASV in high risk patients, after cardio-thoracic surgery, is as effective, more user-friendly and as safe as compared to the conventional modes of ventilation…
Primary Objective:- To compare progression-free survival (PFS) as assessed by blinded independent central review (BICR) between sacituzumab govitecan (SG) and pembrolizumab versus treatment of physician*s choice (TPC) and pembrolizumab. Secondary…
•To compare progression-free survival (PFS) as assessed by blinded independent central review (BICR) between sacituzumab govitecan (SG) versus treatment of physician*s choice (TPC)Secondary Objectives:•To compare overall survival (OS) between the 2…
Primary Objective:* To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing (CPET) following 20 weeks of treatment with OM or placeboSecondary…